vs

Side-by-side financial comparison of IPG PHOTONICS CORP (IPGP) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

IPG PHOTONICS CORP is the larger business by last-quarter revenue ($274.5M vs $225.6M, roughly 1.2× Organogenesis Holdings Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 4.8%, a 14.5% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 17.1%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $10.9M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 4.4%).

IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

IPGP vs ORGO — Head-to-Head

Bigger by revenue
IPGP
IPGP
1.2× larger
IPGP
$274.5M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+61.0% gap
ORGO
78.1%
17.1%
IPGP
Higher net margin
ORGO
ORGO
14.5% more per $
ORGO
19.4%
4.8%
IPGP
More free cash flow
ORGO
ORGO
$23.9M more FCF
ORGO
$34.8M
$10.9M
IPGP
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
4.4%
IPGP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IPGP
IPGP
ORGO
ORGO
Revenue
$274.5M
$225.6M
Net Profit
$13.3M
$43.7M
Gross Margin
36.1%
Operating Margin
1.2%
28.1%
Net Margin
4.8%
19.4%
Revenue YoY
17.1%
78.1%
Net Profit YoY
69.8%
469.5%
EPS (diluted)
$0.30
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IPGP
IPGP
ORGO
ORGO
Q4 25
$274.5M
$225.6M
Q3 25
$250.8M
$150.9M
Q2 25
$250.7M
$101.0M
Q1 25
$227.8M
$86.7M
Q4 24
$234.3M
$126.7M
Q3 24
$233.1M
$115.2M
Q2 24
$257.6M
$130.2M
Q1 24
$252.0M
$110.0M
Net Profit
IPGP
IPGP
ORGO
ORGO
Q4 25
$13.3M
$43.7M
Q3 25
$7.5M
$21.6M
Q2 25
$6.6M
$-9.4M
Q1 25
$3.8M
$-18.8M
Q4 24
$7.8M
$7.7M
Q3 24
$-233.6M
$12.3M
Q2 24
$20.2M
$-17.0M
Q1 24
$24.1M
$-2.1M
Gross Margin
IPGP
IPGP
ORGO
ORGO
Q4 25
36.1%
Q3 25
39.5%
Q2 25
37.3%
Q1 25
39.4%
72.6%
Q4 24
38.6%
75.5%
Q3 24
23.2%
76.7%
Q2 24
37.3%
77.6%
Q1 24
38.7%
73.9%
Operating Margin
IPGP
IPGP
ORGO
ORGO
Q4 25
1.2%
28.1%
Q3 25
3.1%
13.7%
Q2 25
0.0%
-12.5%
Q1 25
0.8%
-30.9%
Q4 24
6.0%
8.1%
Q3 24
-108.7%
5.4%
Q2 24
4.7%
-10.7%
Q1 24
7.6%
-3.5%
Net Margin
IPGP
IPGP
ORGO
ORGO
Q4 25
4.8%
19.4%
Q3 25
3.0%
14.3%
Q2 25
2.6%
-9.3%
Q1 25
1.6%
-21.7%
Q4 24
3.3%
6.1%
Q3 24
-100.2%
10.7%
Q2 24
7.8%
-13.1%
Q1 24
9.6%
-1.9%
EPS (diluted)
IPGP
IPGP
ORGO
ORGO
Q4 25
$0.30
$0.31
Q3 25
$0.18
$0.11
Q2 25
$0.16
$-0.10
Q1 25
$0.09
$-0.17
Q4 24
$0.27
$0.05
Q3 24
$-5.33
$0.09
Q2 24
$0.45
$-0.13
Q1 24
$0.52
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IPGP
IPGP
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$839.3M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.1B
$300.1M
Total Assets
$2.4B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IPGP
IPGP
ORGO
ORGO
Q4 25
$839.3M
$93.7M
Q3 25
$870.4M
$63.7M
Q2 25
$899.6M
$73.1M
Q1 25
$926.9M
$110.0M
Q4 24
$930.2M
$135.6M
Q3 24
$1.0B
$94.3M
Q2 24
$1.1B
$89.9M
Q1 24
$1.1B
$88.6M
Total Debt
IPGP
IPGP
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
IPGP
IPGP
ORGO
ORGO
Q4 25
$2.1B
$300.1M
Q3 25
$2.1B
$255.1M
Q2 25
$2.1B
$233.2M
Q1 25
$2.1B
$242.9M
Q4 24
$2.0B
$262.9M
Q3 24
$2.1B
$278.5M
Q2 24
$2.3B
$263.5M
Q1 24
$2.3B
$278.0M
Total Assets
IPGP
IPGP
ORGO
ORGO
Q4 25
$2.4B
$598.7M
Q3 25
$2.4B
$509.8M
Q2 25
$2.4B
$461.1M
Q1 25
$2.3B
$467.4M
Q4 24
$2.3B
$497.9M
Q3 24
$2.4B
$446.3M
Q2 24
$2.5B
$443.2M
Q1 24
$2.6B
$458.5M
Debt / Equity
IPGP
IPGP
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IPGP
IPGP
ORGO
ORGO
Operating Cash FlowLast quarter
$28.8M
$39.4M
Free Cash FlowOCF − Capex
$10.9M
$34.8M
FCF MarginFCF / Revenue
4.0%
15.4%
Capex IntensityCapex / Revenue
6.5%
2.1%
Cash ConversionOCF / Net Profit
2.17×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-3.5M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IPGP
IPGP
ORGO
ORGO
Q4 25
$28.8M
$39.4M
Q3 25
$35.3M
$3.1M
Q2 25
$-2.2M
$-32.9M
Q1 25
$13.4M
$-19.9M
Q4 24
$73.8M
$10.9M
Q3 24
$66.1M
$8.7M
Q2 24
$53.5M
$4.7M
Q1 24
$54.6M
$-10.2M
Free Cash Flow
IPGP
IPGP
ORGO
ORGO
Q4 25
$10.9M
$34.8M
Q3 25
$14.6M
$844.0K
Q2 25
$-17.6M
$-36.5M
Q1 25
$-11.4M
$-23.6M
Q4 24
$50.6M
$7.6M
Q3 24
$43.0M
$6.1M
Q2 24
$29.2M
$2.9M
Q1 24
$26.5M
$-12.4M
FCF Margin
IPGP
IPGP
ORGO
ORGO
Q4 25
4.0%
15.4%
Q3 25
5.8%
0.6%
Q2 25
-7.0%
-36.1%
Q1 25
-5.0%
-27.2%
Q4 24
21.6%
6.0%
Q3 24
18.4%
5.3%
Q2 24
11.3%
2.2%
Q1 24
10.5%
-11.3%
Capex Intensity
IPGP
IPGP
ORGO
ORGO
Q4 25
6.5%
2.1%
Q3 25
8.3%
1.5%
Q2 25
6.1%
3.6%
Q1 25
10.9%
4.2%
Q4 24
9.9%
2.7%
Q3 24
9.9%
2.2%
Q2 24
9.4%
1.4%
Q1 24
11.1%
2.0%
Cash Conversion
IPGP
IPGP
ORGO
ORGO
Q4 25
2.17×
0.90×
Q3 25
4.73×
0.14×
Q2 25
-0.34×
Q1 25
3.58×
Q4 24
9.44×
1.43×
Q3 24
0.71×
Q2 24
2.65×
Q1 24
2.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IPGP
IPGP

Materials Processing$232.8M85%
Laser And Non Laser Systems$38.8M14%
Transferred Over Time$5.3M2%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons